ProShares UltraShort Health Care
1 hedge funds and large institutions have $48K invested in ProShares UltraShort Health Care in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.
1,404% more call options, than puts
Call options by funds: $76.3M | Put options by funds: $5.08M
37.93% less ownership
Funds ownership: 41.84% → 3.91% (-38%)
67% less funds holding
Funds holding: 3 → 1 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
91% less capital inflows, than outflows
Capital inflows: $48.3K | Capital outflows: $531K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$48.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$289K |
| 2 |
Jane Street
New York
|
-$235K |
| 3 |
Valeo Financial Advisors
Carmel,
Indiana
|
-$6.92K |
RXD Hedge Fund Activity: Q4 2017 in Review
1 of the 4,420 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort Health Care (RXD) for Q4 2017, worth a combined $48K — down 91% from $531K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of RXD and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was UBS Group, opening a new position worth an estimated $48.3K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $289K sold.
- 1 institutional investor held ProShares UltraShort Health Care (RXD) as of Q4 2017, down from 3 in Q3 2017.
- Funds reported $48K of ProShares UltraShort Health Care stock for Q4 2017, down 91% quarter-over-quarter.
- 1 fund opened new ProShares UltraShort Health Care positions in Q4 2017 and 3 closed out, a net change of -2 holders.
- The largest ProShares UltraShort Health Care buyer in Q4 2017 was UBS Group, an estimated $48.3K added.
- The largest ProShares UltraShort Health Care seller in Q4 2017 was Susquehanna International Group, an estimated $289K sold.
Based on aggregated 13F filings for Q4 2017.